Cargando…

Author correction to ‘Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome’ [Acta Pharmaceutica Sinica B 9 (2019) 734–744]

Detalles Bibliográficos
Autores principales:	Wang, Zhilei, Xu, Guang, Gao, Yuan, Zhan, Xiaoyan, Qin, Nan, Fu, Shubin, Li, Ruisheng, Niu, Ming, Wang, Jiabo, Liu, Youping, Xiao, Xiaohe, Bai, Zhaofang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745052/ https://www.ncbi.nlm.nih.gov/pubmed/33354512 http://dx.doi.org/10.1016/j.apsb.2020.09.011

Ejemplares similares

Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome
por: Wang, Zhilei, et al.
Publicado: (2019)

Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ [Acta Pharmaceutica Sinica B 12 (2022) 1567–1590]
por: Li, Guangdi, et al.
Publicado: (2023)

Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ [Acta Pharmaceutica Sinica B 12 (2022) 1198–1212]
por: Wu, Yunhao, et al.
Publicado: (2022)

Author correction to “Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers” [Acta Pharmaceutica Sinica B 11 (2021) 355–372]
por: Jiang, Tingting, et al.
Publicado: (2022)

Author correction to ‘Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models’ [Acta Pharmaceutica Sinica B 11(2021) 1903–1913]
por: Yu, Ziru, et al.
Publicado: (2023)

Author correction to ‘Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models’ [Acta Pharmaceutica Sinica B 11 (2021) 1903–1913]
por: Yu, Ziru, et al.
Publicado: (2023)

Author correction to “Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]
por: Wu, Canhao, et al.
Publicado: (2023)

Author correction to ‘Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication’ [Acta Pharmaceutica Sinica B 9 (2019) 769–781]
por: Huang, Meng-Hao, et al.
Publicado: (2020)

Erratum to “Identification of anti-Mycobacterium tuberculosis agents targeting the interaction of bacterial division proteins FtsZ and SepFe” [Acta Pharmaceutica Sinica B 13 (2023) 2056–2070]
por: Zhang, Hongjuan, et al.
Publicado: (2023)

Icariside Ⅱ, a main compound in Epimedii Folium, induces idiosyncratic hepatotoxicity by enhancing NLRP3 inflammasome activation
por: Wang, Zhilei, et al.
Publicado: (2020)

Author correction to ‘Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents’ [Acta Pharmaceutica Sinica B 9 (2019) 335–350]
por: Wang, Jiabing, et al.
Publicado: (2022)

Author correction to “A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer’s disease” [Acta Pharmaceutica Sinica B 12, (2021) 4032–4044]
por: Lei, Ting, et al.
Publicado: (2022)

Author correction to ‘Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer’ [Acta Pharmaceutica Sinica B 2019; 9(5):1061–1077]
por: Mei, Dong, et al.
Publicado: (2020)

Author correction to ‘Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy’ [Acta Pharmaceutica Sinica B 11 (2021) 3508–3526]
por: Wang, Shuyi, et al.
Publicado: (2023)

Author correction to ‘TMEM16A inhibits angiotensin II-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner’ [Acta Pharmaceutica Sinica B 11 (2021) 3994–4007]
por: Zheng, Huaqing, et al.
Publicado: (2023)

Author correction to “YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer” [Acta Pharmaceutica Sinica B 12 (2022) 2845–2858]
por: Lai, Fangfang, et al.
Publicado: (2023)

Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B 12 (2022) 3934–3951]
por: Yang, Xuan, et al.
Publicado: (2023)

Echinatin effectively protects against NLRP3 inflammasome–driven diseases by targeting HSP90
por: Xu, Guang, et al.
Publicado: (2021)

Author correction to ‘Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo’ [Acta Pharmaceutica Sinica B 11 (2021) 3950–3965]
por: Deng, Linglong, et al.
Publicado: (2023)

NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation
por: Wang, Zhilei, et al.
Publicado: (2022)

Author correction to “DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS‒STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis” [Acta Pharmaceutica Sinica B 12 (2022) 262–273]
por: Wang, Yuanyuan, et al.
Publicado: (2023)

The chloroplast genome of an important herb species, Ephedra sinica (Ephedraceae)
por: Lin, Yifeng, et al.
Publicado: (2019)

Remarks from Editor-in-Chief on the celebration of the 65th anniversary of Acta Biochimica et Biophysica Sinica
por: Ding, Jianping
Publicado: (2023)

Scientia Pharmaceutica, Autorenhinweise 2013
Publicado: (2013)

Scientia Pharmaceutica, Autorenhinweise 2015
Publicado: (2015)

Scientia Pharmaceutica, Autorenhinweise 2016
Publicado: (2016)

Tricyclic antidepressants induce liver inflammation by targeting NLRP3 inflammasome activation
por: Mu, Wenqing, et al.
Publicado: (2023)

Author correction to ‘Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice’ [Acta Pharmaceutica Sinica B 13 (2023) 1164–1179]
por: Fan, Xiaoqing, et al.
Publicado: (2023)

Acknowledgement to Reviewers of Scientia Pharmaceutica in 2017
Publicado: (2018)

Icariside I specifically facilitates ATP or nigericin-induced NLRP3 inflammasome activation and causes idiosyncratic hepatotoxicity
por: Gao, Yuan, et al.
Publicado: (2021)

Asari Radix et Rhizoma consumption lacks relevance for hepatocellular carcinoma in patients: A retrospective cohort study
por: Fang, Zhi-e, et al.
Publicado: (2022)

The Successful Relaunch of Scientia Pharmaceutica Continues Achieving Success
por: Kubelka, Wolfgang, et al.
Publicado: (2011)

734. Abnormal Lipid Profiles in Human Babesiosis
por: Mann, Inderjit, et al.
Publicado: (2021)

An overview of the potential anticancer properties of cardamonin
por: Ramchandani, Shanaya, et al.
Publicado: (2020)

Ameliorative Effects of Cardamonin on Monosodium Urate-Induced Gouty Arthritis through Inhibiting NLRP3 Inflammasome Mediation
por: Wang, Chih-Chien, et al.
Publicado: (2021)

PharmActa: Empowering Patients to Avoid Clinical Significant Drug–Herb Interactions
por: Spanakis, Marios, et al.
Publicado: (2019)

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
por: Zhan, Xiaoyan, et al.
Publicado: (2023)

The Asprosin–OLFR734 module regulates appetitive behaviors
por: Liu, Yang, et al.
Publicado: (2020)

RANKL Signaling and Osteoclastogenesis Is Negatively Regulated by Cardamonin
por: Sung, Bokyung, et al.
Publicado: (2013)

The role of NLRP3 inflammasome in psychotropic drug-induced hepatotoxicity
por: Mu, Wenqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_72ku6jqbe3vea9bkghik7iil16